blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3215169

EP3215169 - TREATMENT OF ATOPIC DERMATITIS WITH INDIGO NATURALIS OR INDIGO PRODUCING PLANT EXTRACT [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  25.02.2020
Database last updated on 02.11.2024
FormerRequest for examination was made
Status updated on  11.08.2017
FormerThe international publication has been made
Status updated on  05.06.2017
Most recent event   Tooltip27.06.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
Galderma S.A.
Zugerstrasse 8
6330 Cham / CH
[2017/37]
Inventor(s)01 / ANDRES, Philippe
126 Avenue des Termes
06530 Peymeinade / FR
02 / CHANTALAT, Laurent
Le Clos des Oliviers
Entrée B
257 Chemin Rabiac Estagnol
06600 Antibes / FR
03 / LIN, Yin-Ku
CHANG GUNG MEMORIAL HOSPITAL at Keelung
Department of Traditional Chinese Medicine
No. 222 Mai-Chin Road
Keelung 204 / TW
 [2017/37]
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[N/P]
Former [2017/37]Cabinet Becker et Associés
25, rue Louis le Grand
75002 Paris / FR
Application number, filing date16717301.208.04.2016
[2017/37]
WO2016EP57769
Priority number, dateEP2015016306709.04.2015         Original published format: EP 15163067
[2017/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016162488
Date:13.10.2016
Language:EN
[2016/41]
Type: A1 Application with search report 
No.:EP3215169
Date:13.09.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 13.10.2016 takes the place of the publication of the European patent application.
[2017/37]
Search report(s)International search report - published on:EP13.10.2016
ClassificationIPC:A61K36/19, A61K36/315, A61K36/48, A61P17/00, A61K31/573
[2017/37]
CPC:
A61K31/404 (EP,US); A61K31/519 (EP,US); A61K31/573 (EP,US);
A61K36/19 (EP,US); A61K36/315 (EP,US); A61K36/48 (EP,US);
A61K36/70 (US); A61K45/06 (US); A61K9/0014 (US);
A61K9/16 (US); A61P17/00 (EP); A61P37/08 (EP);
A61K2236/33 (US); A61K2236/51 (US); A61K2236/53 (US) (-)
C-Set:
A61K31/573, A61K2300/00 (EP,US);
A61K36/315, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/37]
TitleGerman:BEHANDLUNG VON ATOPISCHER DERMATITIS MIT INDIGO NATURALIS ODER HERSTELLUNG INDIGO-PRODUZIERENDEM PFLANZENEXTRAKT[2017/37]
English:TREATMENT OF ATOPIC DERMATITIS WITH INDIGO NATURALIS OR INDIGO PRODUCING PLANT EXTRACT[2017/37]
French:TRAITEMENT DE LA DERMATITE ATOPIQUE PAR DE L'EXTRAIT D'INDIGO NATUREL OU PAR DE L'EXTRAIT DE PLANTE PRODUISANT DE L'INDIGO[2017/37]
Entry into regional phase05.06.2017National basic fee paid 
05.06.2017Designation fee(s) paid 
05.06.2017Examination fee paid 
Examination procedure05.06.2017Amendment by applicant (claims and/or description)
05.06.2017Examination requested  [2017/37]
05.06.2017Date on which the examining division has become responsible
28.02.2020Despatch of a communication from the examining division (Time limit: M04)
02.07.2020Reply to a communication from the examining division
26.06.2024Despatch of a communication from the examining division (Time limit: M04)
Fees paidRenewal fee
11.04.2018Renewal fee patent year 03
15.04.2019Renewal fee patent year 04
31.03.2020Renewal fee patent year 05
15.04.2021Renewal fee patent year 06
25.03.2022Renewal fee patent year 07
23.03.2023Renewal fee patent year 08
27.03.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]CN1317322  ;
 [X]JP2006241080  ;
 [X]EP0987027  (HAYASHIBARA BIOCHEM LAB [JP]);
 [X]EP1495762  (SANTO TETSUO [JP]);
 [X]EP1495764  (SANTO TETSUO [JP]);
 [ID]EP2489358  (CHANG GUNG MEDICAL FOUNDATION CHANG GUNG MEMORIAL HOSPITAL AT KEELUNG [TW]);
 [XI]WO2014118040  (BRATTSTROEM AXEL [DE]);
by applicantEP2489358
 US8784905
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.